Fact.MR – A Market research and competitive intelligence provider: The ocular implants market is expected to garner a market valuation of US$ 12.54 Bn in 2022, anticipated to register a positive market size at a CAGR of 4.5% in the forecast period 2022-2032 and reach a valuation of US$ 19.47 Bn.
Glaucoma Implants To Account For Lion’s Share In The Global Ocular Implants Market
The Fact.MR market study on the ocular implants market provides deep dive into key developments in the ocular implants market. The report offers a comprehensive analysis of leading segments in terms of product type, application type, and end-use.
Fact.MR – A Market research and competitive intelligence provider: The ocular implants market is expected to garner a market valuation of US$ 12.54 Bn in 2022, anticipated to register a positive market size at a CAGR of 4.5% in the forecast period 2022-2032 and reach a valuation of US$ 19.47 Bn.
Increasing incidence of eye disorders such as age-related macular degeneration, cataract, glaucoma, and scleritis is the major factor expected to drive the market. The rise in the incidence rate is leading to an increase in demand for surgical procedures that require ocular implants.
One crucial factor that indicates this is the major shift towards online education programs and the work from home model. This is leading to a higher percentage of the population being exposed to a relatively high amount of screen time, which can lead to the risk of developing eye disorders.
For Critical Insights on This Market, Request for More Info
https://www.factmr.com/connectus/sample?flag=RM&rep_id=7144
Eye diseases such as cataracts and age-related macular degeneration are age-related diseases. A rise in the geriatric population is another factor contributing to the growth of the market.
Technological advancement is yet another factor playing an important role in driving the market growth. The introduction of micro-invasive glaucoma devices for patients suffering from glaucoma is a classic example of the technology that has evolved over the last few years.
For instance, Glaukos Corporation received FDA approval for its second-generation trabecular meshwork bypass stent, iStent Inject in June 2018.
| Report Attributes | Details |
| Ocular implants Market Size (2022) | US$ 12.54 Bn |
| Sales Forecast for ocular implants (2032) | US$ 19.47 Bn |
| Global Market Growth Rate (2022 to 2032) | 4.5% CAGR |
Key Takeaways:
- The United States dominates the market with 35% of the market share
- The Asia Pacific ocular implants market is expected to register the fastest market size at a CAGR of 7.1% during the forecast period.
- By product type, glaucoma implants to capture 25% revenue in the global market.
- By application, the glaucoma surgery segment accounts for the largest revenue share of over 30% owing to the rising incidence of glaucoma, coupled with the growing awareness regarding the disease.
- By end-user, the hospitals’ segment dominates the market for ocular implants, holding a revenue share of more than 40%.
Growth Drivers:
- The increase in the incidence rate is leading to a rise in demand for surgical procedures that require ocular implants in the market.
- Increasing adoption of a sedentary lifestyle and the rising prevalence of diabetes may lead to diabetic retinopathy, which is anticipated to boost the sales of ocular implants in the market.
To gain in-depth insights on the Ocular Implants Market, request methodology at:
https://www.factmr.com/connectus/sample?flag=RM&rep_id=7144
Competitive Landscape:
The competitive landscape of the Ocular Implants Market focuses on one major factor that indicates this is the major shift towards online education programs and the work from home model
- In August 2021, Alcon, Inc., a subsidiary of Novartis, acquired Ivantis, Inc. and its HydrusMicrostent for surgical glaucoma. The intended acquisition supports Alcon’s commitment to further strengthen its industry-leading portfolio across refractive, retina, cataract, and glaucoma.
Key Companies Profiled by Fact.MR
- Alcon Inc.
- Bausch & Lomb Inc. (Bausch Health Companies Inc.)
- Carl Zeiss AG
- Johnson & Johnson
- Morcher GmbH
More valuable insights on the Ocular Implants Market:
Fact.MR, in its report, offers a market analysis of the global Ocular Implants Market the forecast period through 2022 and beyond. This survey reveals the growth of health area in the Ocular Implants Market with detailed segmentation as follows
- By Product
- Intraocular Lens
- Corneal Implants
- Orbital Implants
- Glaucoma Implants
- Ocular Prosthesis
- Others
- By Application
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-related Macular Degeneration
- Aesthetic Purpose
- By End Use
- Hospitals
- Specialty Eye Institutes
- Clinics
Key Questions covered in the Ocular Implants Market Report
What is the projected growth rate for the global market for ocular implants?
How much was the global market for ocular implants worth in 2021?
What is the projected market value of ocular implants in 2022?
At what rate did ocular implants sales flourish from 2015-2021?
What is the expected market value for ocular implants in 2032?
Explore Fact.MR’s Coverage on the Healthcare Domain -
Recombinant Protein Market Scope: Recombinant protein technology has become the standard, with current shifts in focus from bulk production methods to post-production techniques, promising enhanced stability and delivery.
Mobile Retina Services Market Scope - The market for mobile retina services is being driven by a rising number of diabetic patients with retinopathy, patients having laser treatments, and routine diagnostics due to increased awareness. The availability of emergency assistance at the site of the incident will enhance demand for mobile retina services.
Retinal Biosimilars Market Analysis - The rising prevalence and recurrence of retinal illnesses is projected to be a major driver of market expansion for retinal biosimilars in the coming years. Various activities carried out by various organizations around the world raised awareness about ophthalmic illness treatment and diagnosis.
Glaucoma Therapeutics Market Insights - A number of technical breakthroughs in drug delivery are expected to expand the spectrum of glaucoma therapeutics. Implantable extended-release devices, polymer-based contact lenses, and intraocular delivery technologies are among the innovations.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR